423 results about "Axon" patented technology

Apparatus for actuating a skeletal muscle of a patient is provided. The apparatus typically includes a plurality of electrodes, which are adapted to be placed in a vicinity of a motor nerve that innervates the skeletal muscle. A control unit, is preferably adapted to drive a current between two or more of the plurality of electrodes, and to configure the current such that a first subset of axons in the nerve is excited by the current and such that a second subset of axons in the nerve is not excited by the current.

A flat interface nerve electrode is provided along with a method for its use. The electrode provides a plurality of conductive elements embedded in a non-conductive cuff structure, which acts to gently and non-evasively redefine the geometry of a nerve through the application of a force so as to apply pressure to a nerve in a defined range, namely from 2 to 40 mmHG and more preferably from 15 to 30 mmHG and most preferably from 15 mmHG to 20 MMHG. This range is selected to minimize the reduction of blood flow within the tissue, which preferably is at least 70% of the initial value, more preferably 90% of the initial value. The cuff has an opening, which is elongated relative to the diameter of the nerve to which it is applied. Preferably, the cuff is constructed from an elastic bio-compatible material having top and bottom beam members configured to define a nerve opening. The cuff is open at one side and has a connection at the other side which results in a spring force being applied through the surfaces of the nerve opening to the subject nerve. During implantation the open sides of the cuff are closed so as to capture the nerve in the cuff. As the nerve is reshaped, specific nerve axons become more easily addressed through the epineurium by the embedded conductive elements.

PCT No. PCT/JP97/04203 Sec. 371 Date May 20, 1999 Sec. 102(e) Date May 20, 1999 PCT Filed Nov. 19, 1997 PCT Pub. No. WO98/22155 PCT Pub. Date May 28, 1998The present invention offers an artificial tube for nerve which can remain in the body until the nerve regenerates while does not remain as a foreign body in the body following nerve regeneration, and which induces axons regenerated from severed nerve stumps, can promote infiltration of blood capillaries from the body and regeneration of nerve tissue. The present invention comprises a tube 10 or 20 having coating layers 12, 13 or 22, 23 composed of gelatin or collagen on the inner and outer surfaces of a tube 11 or 21 composed of a material being biodegradable and absorbable in vivo, and a collagen body 30 or 40 having cavities 32, 33 or 41 which pass through said tube so as to be substantially parallel to the axis of said tube; wherein, said cavities are filled with a matrix gel.

A memory-centric neural network system and operating method thereof includes: a processing unit; semiconductor memory devices coupled to the processing unit, the semiconductor memory devices contain instructions executed by the processing unit; weight matrixes including a positive weight matrix and a negative weight matrix constructed with rows and columns of memory cells, inputs of the memory cells of a same row are connected to one of Axons, outputs of the memory cells of a same column are connected to one of Neurons; timestamp registers registering timestamps of the Axons and the Neurons; and a lookup table containing adjusting values indexed in accordance with the timestamps, the processing unit updates the weight matrixes in accordance with the adjusting values.

The present invention is a natural, cell-free tissue replacement that does not require difficult or extensive preparation made by washing tissue replacement in a solution including one or more sulfobetaines and an anionic surface-active detergent and washing the tissue replacement in serial solutions of the buffered salt to remove excess detergent. The natural, cell-free tissue replacement may be a nerve graft that supports axonal regeneration, guides the axons toward the distal nerve end and/or is immunologically tolerated. Other forms of the invention are a composition and kit prepared by the method of making a native, cell-free tissue replacement. The present invention may be modified for use in diagnostic, therapeutic, and prophylactic applications.

A tissue-engineered peripheral nerve for reparing the demaged peripheral nerve is composed of neural canal and neuroglia cells or stem cells, and is prepared through preparing neural canal, preparing neurotrophic factor release controllable microspheres, and configuring the tissue-engineered peripheral nerve.

Disclosed is a digital neural processor comprising at least one neural processing element. The neural processing elements including at least one simulated dendrite and a simulated axon. Each of the simulated dendrites may include: a dendrite input capable of receiving at least one dendrite input signal and a dendrite signal propagation function capable of calculating a dendrite output signal in discrete time steps from each dendrite input signal. The signal propagation function may further include a delay parameter; a duration parameter; and an amplitude parameter. The simulated axon includes an axon input capable of receiving dendrite output signals, an axon function, capable of calculating an axon output signal from dendrite output signal(s) and an axon output capable of outputting the axon output signal.

Methods and systems for the treatment for ALS incorporating stem cells harvested from the subject to be treated. These stem cells may be genetically altered with the addition of several genes of interest. Then, the patient will receive systemic gene therapy for the muscles and directed specifically at motor neurons. In this multi-pronged treatment approach, the stem cells provide immune regulation and the regeneration of motor neurons. And, the new motor neurons carry the added genes, which are protective against motor neuron death from ALS. The systemic therapy increases the amount of genes, which further reduces the effects of ALS. Additional gene therapy administered in the muscle will be further protective of the axon, while maintaining muscle mass and function.

Provided in the invention is a multi-mode neural morphological network core comprising a mode register, an axon input unit, a synaptic weight storage unit, a dendrite unit and a neuron computing unit. According to the multi-mode neural morphological network core, both artificial neural network computing and impulsive neural network computing can be carried out; and switching between an artificial neural network operation mode and an impulsive neural network operation mode can be realized according to demands.

A control system for use with a neurostimulator comprises a user interface for receiving an input from a user and a controller. The user interface has a first control and a second control. The controller is configured for, in response to actuating the first control, operating the neurostimulation control system in a PNFS programming mode, and for, in response to actuating the second control, operating the neurostimulation control system in a PNS programming mode. A method of providing therapy to a patient comprises initially conveying pulsed electrical current at a pulse width into a peripheral tissue region of the patient to create a side effect via stimulation of one of a nerve ending and neural axon, and subsequently conveying pulsed electrical current at an adjusted pulse width into the peripheral tissue region to create a therapeutic effect via stimulation of the other one of the nerve ending and neural axon.

A long term bi-directional axon-electronic communication system that provides signaling capability at the level of individual nerve fascicles, bundles of axon and even axons is disclosed. The bi-directional communication system is a modular approach for achieving a chronic enduring interface to peripheral or central nerve atoms for the purpose of restoring function to disabled persons or animals with sensory and/or motor impairments. One embodiment of the communication system includes a multi-channeled nerve-muscle graft chamber for making the nerve-muscle connection. Another embodiment includes a regeneration based microtube nerve interface for bi-directional communication. The interface communication system permits amputees to obtain simultaneous control of multi-degree of freedom powered prostheses by means of naturally produced neural activity from the stamps of the amputated nerves in their residual limbs.

Methods and compositions are disclosed for the use of allogeneic mononuclear phagocytes to promote axonal regeneration in the central nervous system of a mammal. In one embodiment, allogeneic mononuclear phagocytes are cultured together with stimulatory tissue, such as skin, dermis or at least one nerve segment, and are subsequently administered into the central nervous system of a mammal at or near a site of injury or disease. In an alternative embodiment, autologous monocytes, preferably stimulated autologous monocytes, are administered into the central nervous system of a mammal at or near a site of injury or disease. CNS administration of mononuclear phagocytes may optionally be combined with administration of an adjuvant factor (e.g. aFGF) to the CNS, anti-inflammatory therapy of the mammal, or both. Methods for screening stimulatory tissue and cells and methods and compositions for cryopreserved allogeneic mononuclear phagocytes are also disclosed.

A method of treating a patient with an ailment, comprises delivering first energy to a dorsal root ganglia (DRG), thereby modulating the DRG, and delivering second energy to at least one of a central neural axon extending from the DRG and a peripheral neural axon extending from the DRG, thereby modulating the at least one of the central neural axon and the peripheral neural axon.

Recovery from peripheral nerve and nerve plexus injuries is usually slow and incomplete because the regenerating motor axons often head erroneously toward sensory receptors rather than muscle fibers and because the target muscles atrophy while waiting for the slow process of reinnervation. Research has suggested that electrical stimulation with different waveforms and temporal patterns at different times during the regeneration process might improve the clinical outcome through various mechanisms, but a practical means to deliver such stimulation has been lacking. This invention teaches the use of miniature electrical stimulators that can be implanted alongside the injured nerve(s) at the time of surgical repair and that can be powered and controlled by transmission of radiofrequency energy from outside the body so as to provide a variety of electrical stimuli at different times during the recovery process.

A keratin hydrogel matrix serves as an effective acellular scaffold for axonal regeneration and facilitates functional nerve recovery.

Described herein is conduit material that causes minimal inflammatory reaction, and serves as a structural guide for regenerating nerve tissue (e.g., axons). Thus, the invention is directed to methods of treating a nerve injury in an individual in need thereof. The methods employ an isolated, naturally occurring epineural sheath, and can be used, for example, to regenerate nerve tissue in an individual in need thereof. Also provided herein is a device for harvesting an epineural sheath.

The invention proposes a neuromorphic chip simulator. The simulator comprises a plurality of processing cores and a plurality of routers. Each processing core comprises an input buffer area, a processing module, a dendritic calculation unit, a cell body calculation unit and an output buffer area. The dendritic calculation unit comprises a memory array and N simulated neurons; each simulated neuron comprises M axon inputs; and the dendritic calculation unit performs multiplication on the axon input of each position on each simulated neuron and a synaptic weight of a corresponding position, accumulates multiplication results, and combines accumulated results obtained by all the simulated neurons as output data of the dendritic calculation unit. The cell body calculation unit comprises N simulated neurons; each simulated neuron performs accumulation on a result obtained by multiplication and addition in the dendritic calculation unit and a numerical value accumulated by the previous simulated neuron; and pulses are generated when an accumulated numerical value exceeds a preset threshold. The output buffer area stores pulse-containing data packets. According to the simulator, the quality and efficiency of a neuromorphic chip design process can be ensured and designers can design neuromorphic chips with higher quality more quickly.